brinzolamide has been researched along with Congenital X-Linked Retinoschisis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leo, SW; Willyasti, K; Yang, FP | 1 |
Anderson, RJ; Andreuzzi, P; Fishman, GA | 1 |
2 other study(ies) available for brinzolamide and Congenital X-Linked Retinoschisis
Article | Year |
---|---|
Topical brinzolamide for foveal schisis in juvenile retinoschisis.
Topics: Administration, Topical; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Humans; Male; Retinoschisis; Sulfonamides; Thiazines; Treatment Outcome | 2013 |
USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroretinography; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retinoschisis; Retrospective Studies; Sulfonamides; Thiazines; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Young Adult | 2017 |